Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adenoviral vector and methods of use

Recombinant adenoviral vector and methods of use

US Patent 6989268 · Granted Jan 24, 2006

Estimated economic value: $141,642,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy with an anti-hyaluronan agent and therapeutic agent2018
Combination therapy with an anti-hyaluronan agent and therapeutic agent2018
Cell lines for production of replication-defective adenovirus2010
Nucleic acid delivery2008
Adenovirus vectors for gene therapy2008
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neop2007
DNA molecules stabilized for propagation in bacterial cells that encode cystic f2006
Method of using an adenoviral vector encoding a retinoblastoma protein to treat 2006
Method of using an adenoviral vector encoding a retinoblastoma protein to treat 2006
Method of using an adenoviral vector encoding a retinoblastoma protein to treat 2006
Nucleic acid delivery2006
Compositions and methods for inducing gene expression2006